Boost Home Healthcare

Item 7 in the 2025 FDD lays out a single-unit investment of $157,650 to $312,750, including a hefty $60,000 franchise fee. Ongoing fees stack up with 5% royalties (dropping to 3.5% on Medicaid collections), 2% brand fund, plus fixed $1,250 monthly for software ($750 min) and tools ($500), and insurance running $625-$1,167 per month. No Item 19 means no disclosed earnings, a red flag in healthcare where margins can vary wildly from payer mix—leaving you to rely on FDD Item 20's flat growth: 6 locations steady from 2023-2024, with zero net adds amid 1 termination and no transfers.

System health shows caution: just 6 franchised units under private equity parent The Riverside Company, which acquired the brand recently. Two SBA loans average $334,000, suggesting some scale-up financing but tiny sample size. Projected 23 new units signal ambition, yet flat history and no revenue transparency amplify risks in a competitive field. For hands-on operators with healthcare experience, the lower-end investment might appeal, but expect patient acquisition hurdles without proven AUVs.